Shira Peleg-Hasson

16PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyEpidemiological modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 13, 2026
Molecular Profiling to Guide Fertility Sparing Therapy in Early-Stage Endometrial Cancer: A EORTC Gynaecological Cancer Group Study.

|Sep 08, 2024
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.

Luke Steventon, Kenneth K C Man, Shibani Nicum

|Jul 04, 2024
Top advances of the year: Immunotherapy in endometrial cancer.

Susana Banerjee, Shira Peleg Hasson

|Jan 19, 2024
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors.

Shira Peleg Hasson, Eliya Shachar, Miriam R Brezis

|Sep 09, 2023
Cost-Utility Analysis of Open Radical Hysterectomy Compared to Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.

Nadav Michaan, Moshe Leshno, Gil Fire

|Apr 17, 2023
Effect of BMI change on recurrence risk in patients with endometrial cancer.

Ido Laskov, Ayala Zilberman, Lihie Maltz-Yacobi

Pageof 3

Frequent Collaborators

3 joint publications

Nadav Michaan

2 joint publications

Eliya Shachar

2 joint publications

Akram Saad

1 joint publications

Ben Shofty